79340798

Information

• Trademark
• 79340798

• Source

• Serial Number

  79340798

• Registration Number

  7265238

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 14, 2022
  3 years ago

• Registration Date

  January 09, 2024
  a year ago

• Transaction Date

  March 19, 2025
  16 days ago

• Status Date

  January 09, 2024
  a year ago

• Published for Opposition Date

  October 24, 2023
  a year ago

• Location Date

  January 09, 2024
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  SWIFT, GILBERT

• Attorney Docket Number

  24096.4a.1

  Attorney Name

  David Johnson

  Law Office Assigned Location Code

  L90

• Owners

  • Exscientia AI Limited
  • Exscientia Limited

Case File Statements

• DM0000: The mark consists of the design of a leafless tree with four double circle designs at the extremities.
• GS0091: Downloadable computer software for analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics; Downloadable computer software for computer assisted molecule design; Downloadable computer software for chemical and biological research and analysis; Downloadable computer software for pharmaceutical research and development services; Downloadable computer software for diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes for use in the field of molecular research and to combat disease; downloadable computer software for use in the research and development of pharmaceutical products; downloadable computer software for cell analysis; downloadable computer software for the use in managing scientific projects; downloadable computer software for the design of chemical structures; downloadable computer software for the analysis of biological or chemical activity; downloadable artificial intelligence software for healthcare, pharmaceuticals and diagnostics
• GS0051: Pharmaceutical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Medical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Veterinary preparations for the treatment of pain, viral diseases, namely, paramyxovirus, influenza A virus, coronavirus, herpes, and hepatitis, wounds, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, mental health disorders, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, cardiovascular diseases and disorders, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, arthritis, inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases, immunologic diseases and disorders, namely Alzheimer's, ulcerative colitis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), allergies, and anxiety; veterinary preparations, namely, vaccines for animals, and sanitary substances for medical use for the treatment of autoimmune diseases, autoimmune diseases, specifically psoriasis, arthritis, and Crohn's disease; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use, food for babies; dietetic substances in the nature of dietetic food adapted for medical or veterinary use; Dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings, namely, gauze, bandages; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical, veterinary and sanitary substances and preparations, namely, antifungals, antivirals, herbicides, antibiotics
• GS0441: Medical diagnostic testing and medical screening services
• GS0421: Scientific and technological services, namely, scientific research, analysis, testing in the field of research and development of pharmaceutical products and molecule design and services relating thereto; industrial analysis and industrial research services in the field of research and development of pharmaceutical products, molecule design and robotics for lab automation and industrial design services; quality control and authentication services in the field of works of scientific research for others; design and development of computer hardware and software; Bioinformatic services, namely, analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics for others; computer assisted molecule design; identification of biological targets, networks and pathways; chemical and biological research and analysis; pharmaceutical research and development services; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes to combat diseases

Case File Event Statements

• 11/4/2022 - 2 years ago

  4 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 5/19/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 5/20/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/24/2022 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/25/2022 - 2 years ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 12/26/2022 - 2 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/27/2022 - 2 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/22/2023 - 2 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/22/2023 - 2 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/15/2023 - 2 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 8/21/2023 - a year ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/21/2023 - a year ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/21/2023 - a year ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/16/2023 - a year ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/4/2023 - a year ago

  17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 10/24/2023 - a year ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/4/2023 - a year ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/4/2023 - a year ago

  16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 10/24/2023 - a year ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/25/2023 - a year ago

  21 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 10/24/2023 - a year ago

  20 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 10/25/2023 - a year ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 11/12/2023 - a year ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 1/9/2024 - a year ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/9/2024 - a year ago

  25 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 5/7/2024 - 11 months ago

  29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 6/1/2024 - 10 months ago

  30 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 3/13/2025 - 22 days ago

  31 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 3/13/2025 - 22 days ago

  33 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 3/13/2025 - 22 days ago

  32 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 3/13/2025 - 22 days ago

  34 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/13/2025 - 22 days ago

  35 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/11/2024 - 11 months ago

  28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/9/2024 - 12 months ago

  26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 4/11/2024 - 11 months ago

  27 - FINAL DISPOSITION PROCESSED Type: FIMP